Biodegradable microspheres for parenteral delivery.

University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India.
Critical Reviews in Therapeutic Drug Carrier Systems (Impact Factor: 3.17). 02/2005; 22(6):535-602. DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i6.20
Source: PubMed

ABSTRACT Nowadays, emphasis is being laid to development of controlled release dosage forms. Interest in this technology has increased steadily over the past few years. Although oral administration of drugs is a widely accepted route of drug delivery, bioavailability of drug often varies as a result of gastrointestinal absorption, degradation by first-pass effect, and hostile environment of gastrointestinal tract. Transdermal administration for percutaneous absorption of drug is limited by the impermeable nature of the stratum corneum. Ocular and nasal delivery is also unfavorable because of degradation by enzymes present in eye tissues and nasal mucosa. Hence, the parenteral route is the most viable approach in such cases. Of the various ways of achieving long-term parenteral drug delivery, biodegradable microspheres are one of the better means of controlling the release of drug over a long time. Because of the lipidic nature of liposomes, problems such as limited physical stability and difficulty of freeze-drying are encountered. Similarly, for emulsions, stability on long-term basis and in suspensions, rheological changes during filling, injecting, and storage poses limitation. Also, in all these systems, the release rate cannot be tailored to the needs of the patient. Parenteral controlled-release formulations based on biodegradable microspheres can overcome these problems and can control the release of drug over a predetermined time span, usually in the order of days to weeks to months. Various FDA-approved controlled-release parenteral formulations based on these biodegradable microspheres are available on the market, including Lupron Depot Nutropin Depot and Zoladex. This review covers various molecules encapsulated in biodegradable microspheres for parenteral delivery.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pluronic F127 block copolymer (PF127) has been recognized as an important biomaterial used for the efficient delivery of therapeutic proteins and peptides against various incurable diseases and thereby has gained increasing attention of pharmaceutical researchers. The aim of the present article is to highlight the biopharmaceutical significance of PF127-based thermosensitive gels for sustained delivery of therapeutic proteins and peptides. In this article, we have discussed various approaches adopted by several researchers for sustained release of different proteins and peptides from PF127-based thermosensitive gels. Incorporation of therapeutic proteins and peptides in PF127-based thermosensitive gels have shown to increase thermostability, biocompatibility, bioavailability, and therapeutic effects of these therapeutic agents. Summarizing various studies which have used PF127 as thermosensitive gel for controlled release of therapeutic proteins and peptides with no known toxicity, we conclude that PF127 continues to show its prospective effects for sustained delivery of therapeutic proteins and peptides. Taken together, we can expect a promising future of PF127 as polymer therapeutic for significant clinical outcomes of therapeutic proteins and peptides.
    Polymer Reviews 10/2014; 54(4). DOI:10.1080/15583724.2014.927885 · 6.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to develop a sustained-release drug delivery system based on the injectable PLGA microspheres loaded with andrographolide. The andrographolide loaded PLGA microspheres were prepared by emulsion solvent evaporation method with optimization of formulation using response surface methodology (RSM). Physicochemical characterization, in vitro release behavior and in vivo pharmacokinetics of the optimized formulation were then evaluated. The percent absorbed in vivo was determined by deconvolution using the Loo-Riegelman method, and then the in vitro-in vivo correlation (IVIVC) was established. Results showed that the microspheres were spherical with a smooth surface. Average particle size, entrapment efficiency and drug loading were found to be 53.18±2.11μm, 75.79±3.02% and 47.06±2.18%, respectively. In vitro release study showed a low initial burst release followed by a prolonged release up to 9 days and the release kinetics followed the Korsmeyer-Peppas model. After a single intramuscular injection, the microspheres maintained relatively high plasma concentration of andrographolide over one week. A good linear relationship was observed between the in vitro and in vivo release behavior (R(2)=0.9951). These results suggest the PLGA microspheres could be developed as a potential delivery system for andrographolide with high drug loading capacity and sustained drug release.
    International Journal of Pharmaceutics 09/2014; DOI:10.1016/j.ijpharm.2014.09.016 · 3.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is a need for both new and improved vaccination formulations for a range of diseases for which current vaccines are either inadequate or non-existent. Biodegradable polymer-based vaccines fulfill many of the desired properties in achieving effective long-term protection in a manner that is safe, economical, and potentially more practicable on a global scale. Here we discuss some of the work performed with micro/nanoparticles made from either synthetic (poly(lactic-co-glycolic acid) [PLGA] and polyanhydrides) or natural (chitosan) biodegradable polymers. Our attention is focused on, but not limited to, the generation of antitumor immunity where we stress the importance of particle size and co-delivery of antigen and adjuvant.
    Human Vaccines & Immunotherapeutics 08/2013; 9(12). DOI:10.4161/hv.26136 · 3.64 Impact Factor